Truist Financial Rises, Micron Falls, Novo Nordisk Slides After Trump Touts Lower Ozempic Price
Audio is streamed directly from the publisher (podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
On this episode of Stock Movers:
- Truist Financial (TFC) shares rise after the firm told investors during its earnings conference call that while the bank had no exposure to bankrupt Tricolor Holdings, it has some exposure to First Brands. The bank accounted for this in its non-performing loans, loan loss reserve and 2025 net charge-off guidance, per CFO Mike Maguire.
- Micron (MU) shares falls after a report from Reuters that the chipmaker plans to stop supplying server chips to data centers in China after the business failed to recover from a 2023 government ban on its products in critical Chinese infrastructure.
- Novo Nordisk (NOVO) shares slide after President Donald Trump said the price of the diabetes drug Ozempic could come down to just $150 a month. Talks over the price of weight-loss drugs, including Ozempic, are still ongoing, according to Mehmet Oz, head of the Centers for Medicare and Medicaid Services.
See omnystudio.com/listener for privacy information.